While a cure remains elusive, cancer treatment has seen significant advances in recent years. New innovations include ...

Rockies senior player development director Chris Forbes has spent more than half of his 53 years fighting cancer with a ...

Researchers at Karolinska Institutet have identified two specific receptor proteins in the brain that, when activated, boost the organ’s built-in ability to break down the amyloid-beta plaques ...

The man spending $2 million a year to not die might be the clearest mirror we have for a fear most of us carry quietly, one that started long before any of us ever heard the word 'biomarker.' ...

Insiders profiting off ICE’s real estate deals, whistleblowers gone silent, and more from The Lever this week.

Novo Nordisk said Wednesday that demand for its Wegovy pill got off to a strong start after it launched in the U.S. in early January. By Jan. 23 — less than three weeks after it became available — ...

Novo Nordisk said it will take legal action again telehealth provider Hims & Hers after Hims announced a cheaper copycat version of Novo's Wegovy weight loss pill. Hims said it would sell a copy of ...

Hims & Hers on Saturday said it would stop offering its copycat Wegovy weight-loss pill. The decision comes after Novo Nordisk, maker of Wegovy, and the U.S. Food and Drug Administration threatened ...

There’s a new semaglutide pill entering the weight-loss market, and it’s aiming to undercut the competition. Hims & Hers, the online pharmaceutical retailer, announced plans to launch a compounded, ...

Novo Nordisk has launched its Wegovy GLP-1 drug in pill form. Amazon is getting into the fight, offering ease and low costs to customers who buy the Wegovy pill on its platform. Up until 2026, GLP-1 ...

Share on Pinterest Hims & Hers has withdrawn its low cost compounded weight loss pill after pressure from top U.S. health officials and a major lawsuit. Image courtesy of Novo Nordisk Hims & Hers ...

Yes, Wegovy is available in a pill form. Originally, it was only available as a weekly injection, but the Food and Drug Administration (FDA) approved a daily tablet version in December 2025. The ...